- Report
- January 2023
- 119 Pages
Global
From €4338EUR$4,500USD£3,710GBP
- Report
- February 2024
- 86 Pages
Global
From €3500EUR$3,889USD£3,098GBP
- Report
- August 2023
Japan, United States, ... Japan, United States, Europe
From €1446EUR$1,500USD£1,237GBP
- Report
- April 2022
Japan, United States, ... Japan, United States, Europe, Global
From €2362EUR$2,450USD£2,020GBP
- Report
- December 2021
Global
From €4676EUR$4,850USD£3,999GBP
- Report
- March 2021
- 58 Pages
Global
From €3374EUR$3,500USD£2,886GBP
- Report
- February 2020
- 197 Pages
Japan, United States, ... Japan, United States, Europe, Global
From €4338EUR$4,500USD£3,710GBP
From €578EUR$600USD£495GBP
- Report
- September 2019
Global
From €5177EUR$5,370USD£4,428GBP
Yersinia Test is a type of infectious disease testing used to detect the presence of Yersinia bacteria in a patient's sample. Yersinia is a genus of bacteria that can cause a variety of illnesses, including plague, gastroenteritis, and septicemia. Yersinia tests are used to diagnose and monitor the progression of these illnesses. The test is typically performed on a sample of blood, urine, or tissue.
Yersinia tests are used in both clinical and research settings. In clinical settings, the test is used to diagnose and monitor the progression of Yersinia-related illnesses. In research settings, the test is used to study the epidemiology of Yersinia-related illnesses and to develop new treatments.
The Yersinia Test market is composed of a variety of companies that provide testing services, reagents, and other related products. Examples of companies in the market include Bio-Rad Laboratories, Thermo Fisher Scientific, Abbott Laboratories, and Becton Dickinson. Show Less Read more